Trihexyphenidyl Hydrochloride 2 MG Oral Tablet

INDICATIONS This drug is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. Additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.

Actavis Pharma, Inc.

FDA Reported Adverse Reactions
`[1] off label use` `[2] nausea` `[3] fatigue` `[4] diarrhoea` `[5] drug ineffective` `[6] dyspnoea` `[7] death` `[8] pneumonia` `[9] pyrexia` `[10] vomiting`

4 years ago

ROUND WHITE DAN DAN 5335

4 years ago

DAN DAN 5335 ROUND WHITE

HOW SUPPLIED

TRIHEXYPHENIDYL HYDROCHLORIDE tablets USP, 2 mg are scored, round, white, flat faced, tablets imprinted DAN DAN and 5335 supplied in bottles of 100 (NDC 0591-5335-01) and 1000 (NDC 0591-5335-10).

TRIHEXYPHENIDYL HYDROCHLORIDE tablets USP, 5 mg are scored, round, white, tablets imprinted DAN DAN and 5337 supplied in bottles of 100 (NDC 0591-5337-01) and 1000 (NDC 0591-5337-10). Dispense in a tight container with child-resistant closure. Store at 20° to 25° (68° to 77°F) [See USP Controlled Room Temperature]. Manufactured In India By: Watson Pharma Private Limited Verna, Salcette Goa 403 722 INDIA Manufactured For: Teva Pharmaceuticals Parsippany, NJ 07054 Rev. A 2/2024

More pills like ROUND DAN DAN 5335

Related Pills

Trihexyphenidyl Hydrochloride Trihexyphenidyl Hydrochloride 2 MG Oral Tablet

Watson Laboratories, Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site